Lumos Diagnostics (ASX:LDX) Commences FebriDx CLIA Waiver Study
Lumos Diagnostics announces the launch of the FebriDx CLIA Waiver study, aimed at improving antibiotic use with substantial support from BARDA.
Tag: Investor Relations
Sipa Resources Limited (ASX:SRI) Acquires New Gold Projects
Sipa Resources (ASX:SRI) expands its gold exploration portfolio through the acquisition of four advanced projects in SA and WA.
Sipa Resources Limited (ASX:SRI) Reinstatement to Quotation
Sipa Resources Limited (ASX:SRI) has had its trading suspension lifted following key announcements regarding an acquisition and capital raising.
Geopacific Resources Limited (ASX:GPR) Launches Entitlement Offer
Geopacific Resources launches a renounceable entitlement offer to raise A$40 million for its Woodlark Project development.
Champion Iron Limited (ASX:CIA) Announces Partnership for Kami Project
Champion Iron partners with Nippon Steel and Sojitz to advance the Kami Project, securing substantial financial contributions and expertise.
Orthocell Limited (ASX:OCC) Submits FDA Application for Remplir™
Orthocell submits its FDA application for Remplir™, targeting the US nerve repair market, with clearance expected by April 2025.
Imugene Limited (ASX:IMU) Confirms $11 Million R&D Tax Refund
Imugene Limited (ASX:IMU) secures $11 million R&D tax refund to advance its immuno-oncology therapies.
EBR Systems, Inc. (ASX:EBR) Schedules FDA Pre-Approval Inspection
EBR Systems, Inc. announces a scheduled FDA Pre-Approval Inspection for its wireless cardiac pacing device, a pivotal step in regulatory progress.
Clarity Pharmaceuticals (ASX:CU6) Expands Radiopharmaceutical Pipeline
Clarity Pharmaceuticals (ASX:CU6) unveils a novel radiopharmaceutical, SAR-bisFAP, enhancing cancer diagnosis and treatment potential.
Carbonxt Group Limited (ASX:CG1) Achieves Mechanical Completion of Kentucky Plant
Carbonxt Group Limited (ASX:CG1) has achieved mechanical completion of its Kentucky plant, enhancing its capacity to meet activated carbon market demand.